- |||||||||| cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Trial completion, Enrollment change, Post-transplantation: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer (clinicaltrials.gov) - Aug 31, 2018 P2, N=142, Completed, Phase classification: P=N/A --> P1 | N=15 --> 7 | Active, not recruiting --> Terminated Active, not recruiting --> Completed | N=92 --> 142
- |||||||||| Neupogen (filgrastim) / Kyowa Kirin, Amgen
Phase classification, Enrollment change, Trial termination: Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia (clinicaltrials.gov) - Aug 23, 2018 P1, N=7, Terminated, Active, not recruiting --> Completed | N=92 --> 142 Phase classification: P=N/A --> P1 | N=25 --> 7 | Active, not recruiting --> Terminated; Expiration of study supply
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer (clinicaltrials.gov) - Jul 19, 2018
P=N/A, N=2545, Completed, Trial completion date: Dec 2020 --> Feb 2018 | Active, not recruiting --> Terminated; Low accrual Active, not recruiting --> Completed | Trial completion date: Jan 2100 --> Jun 2018 | Trial primary completion date: Jan 2100 --> Jun 2018
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia (clinicaltrials.gov) - Mar 31, 2018
P1, N=10, Terminated, Active, not recruiting --> Completed N=35 --> 10 | Trial completion date: Mar 2019 --> Aug 2017 | Recruiting --> Terminated | Trial primary completion date: Mar 2018 --> Jul 2017; Insufficient Accrual
- |||||||||| decitabine / Generic mfg.
Trial completion, Enrollment change: AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia (clinicaltrials.gov) - Mar 14, 2018 P1, N=13, Completed, N=35 --> 10 | Trial completion date: Mar 2019 --> Aug 2017 | Recruiting --> Terminated | Trial primary completion date: Mar 2018 --> Jul 2017; Insufficient Accrual Active, not recruiting --> Completed | N=54 --> 13
- |||||||||| Trial completion, Trial primary completion date: Total Marrow Irradiation for Refractory Acute Leukemia (clinicaltrials.gov) - Jul 28, 2017
P1, N=12, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Feb 2016 --> Nov 2016
- |||||||||| Enrollment closed, Enrollment change, Trial primary completion date: Total Marrow Irradiation for Refractory Acute Leukemia (clinicaltrials.gov) - Dec 8, 2016
P1, N=12, Active, not recruiting, Trial primary completion date: Dec 2016 --> Aug 2016 Recruiting --> Active, not recruiting | N=20 --> 12 | Trial primary completion date: Sep 2017 --> Feb 2016
- |||||||||| cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Trial primary completion date, Post-transplantation: Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer (clinicaltrials.gov) - Oct 18, 2016 P2, N=92, Active, not recruiting, Recruiting --> Active, not recruiting Trial primary completion date: Jan 2015 --> Apr 2017
- |||||||||| Biomarker, Trial completion, Trial primary completion date, Heterogeneity: Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=20, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> Jul 2016 Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> Jul 2016
- |||||||||| Trial completion, Trial primary completion date: Cell Samples From Patients With Leukemia (clinicaltrials.gov) - May 19, 2016
P=N/A, N=10, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> May 2016 Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> May 2016
- |||||||||| Biomarker, Trial completion, Trial primary completion date: Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia (clinicaltrials.gov) - May 19, 2016
P=N/A, N=234, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> May 2016 Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> May 2016
- |||||||||| Biomarker, Trial completion, Trial primary completion date: Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia (clinicaltrials.gov) - May 19, 2016
P=N/A, N=32, Completed, Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> May 2016 Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> May 2016
|